This statistic shows the total revenue since approval for select cancer drugs that were on the market as of 2017. As of that year, Alexion Pharmaceuticals' drug Eculizumab generated a total revenue of nearly ** billion U.S. dollars since the drug's approval in **********.
This statistic includes only pharmaceutical companies with a single oncologic drug approved by the Food and Drug Administration (FDA). Values are inflation adjusted for 2017 U.S. dollars.
* Alexion later had two drug approvals in the last quarter of 2015; these drugs are not included in this statistic.
** Compound acquired by the company on this date.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Journal of the American Medical Association. (November 1, 2017). Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars) [Graph]. In Statista. Retrieved July 15, 2025, from https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/
Journal of the American Medical Association. "Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars)." Chart. November 1, 2017. Statista. Accessed July 15, 2025. https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/
Journal of the American Medical Association. (2017). Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars). Statista. Statista Inc.. Accessed: July 15, 2025. https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/
Journal of the American Medical Association. "Total Revenue since Approval for Select Cancer Drugs on The Market as of 2017 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Nov 2017, https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/
Journal of the American Medical Association, Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars) Statista, https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/ (last visited July 15, 2025)
Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars) [Graph], Journal of the American Medical Association, November 1, 2017. [Online]. Available: https://www.statista.com/statistics/788909/revenue-since-approval-for-select-cancer-drugs/
